Summary of Solesence Q2 2026 Earnings Call

1Key Financial Results and Metrics

Revenue: $15.3 million, down from $20.4 million in Q2 2025, primarily due to the absence of a major product launch that had boosted the previous year's figures.

Gross Margin: 31%, slightly down from a restated 32% in Q2 2025, indicating improved labor efficiency despite lower revenue.

Net Income: Loss of $158,000 compared to a net income of $3.2 million in the prior year.

Adjusted EBITDA: $523,000, down from $3.7 million in Q2 2025, influenced by lower revenue and one-time events affecting net income.

Future Orders: As of August 17, 2026, shipped and on-hand orders totaled $64.9 million, up from $60 million in the same period last year.

2Strategic Updates and Business Highlights

Management is focused on addressing a legacy accounting issue related to inventory costing methodology, which they are actively remediating.

The company is implementing enhanced inventory costing processes and controls to prevent future discrepancies.

Continued execution of the "Transform and Transcend" strategy aimed at operational efficiency.

Launch of new scalp care products, including a combination dry shampoo and SPF product, which is positioned in a $3 billion addressable market.

3Forward Guidance and Outlook

Management is confident in outperforming 2025 on a full-year revenue basis, projecting approximately $35 million in revenue for the second half of 2026, which would mark the strongest second-half performance in company history.

Anticipated sequential improvement in both revenue and profitability in Q3 2026.

4Bad News, Challenges, or Points of Concern

The company is dealing with an accounting matter that has led to restatements, which could impact stakeholder confidence.

The decline in revenue and profitability metrics compared to the previous year raises concerns about operational performance.

Ongoing challenges in inventory control and production efficiency have been highlighted, although management expresses optimism about improvements.

5Notable Q&A Insights

Management confirmed that the scalp care segment is a new market for Solesence, with promising early feedback from product launches.

There is a focus on improving production efficiency and inventory control, with management expressing optimism about recent advancements.

The company is exploring further collaboration with REFY on new product formulations following a recent settlement.

Management reassured investors that the accounting issues do not impact the underlying cash flow or operational capabilities of the business. Overall, while Solesence faces challenges related to accounting and revenue declines, management remains optimistic about future growth, operational improvements, and the potential of new product lines.